
Pomalidomide-PEG3-C2-NH2
CAS No. 2093416-31-8
Pomalidomide-PEG3-C2-NH2( Cereblon Ligand-Linker Conjugates 5 | E3 ligase Ligand-Linker Conjugates 30 )
Catalog No. M26944 CAS No. 2093416-31-8
Pomalidomide-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide based cereblon ligand and 3-unit PEG linker.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
![]() ![]() |
10MG | 590 | Get Quote |
![]() ![]() |
25MG | 1060 | Get Quote |
![]() ![]() |
50MG | 1591 | Get Quote |
![]() ![]() |
100MG | 2387 | Get Quote |
![]() ![]() |
200MG | 3580 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePomalidomide-PEG3-C2-NH2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide based cereblon ligand and 3-unit PEG linker.
-
DescriptionPomalidomide-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide based cereblon ligand and 3-unit PEG linker.
-
In Vitro——
-
In Vivo——
-
SynonymsCereblon Ligand-Linker Conjugates 5 | E3 ligase Ligand-Linker Conjugates 30
-
PathwayOthers
-
TargetOther Targets
-
RecptorMRCK| ROCK1| ROCK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2093416-31-8
-
Formula Weight448.476
-
Molecular FormulaC21H28N4O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCCOCCOCCOCCNc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yen Ting Chen, et al. Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors. Med.Chem.Commun., 2011, 2, 73-75.
molnova catalog



related products
-
LY-3475070
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
-
G280-9
The G280-9 peptide, a common melanoma gp100 epitope restricted by MHC-associated HLA-A2. The G280-9 sequence is unique because it could be recognized by cytotoxic T lymphocytes at very low concentrations, however it shows low total immunogenicity that may be attributable to relatively low affinity of this peptide for the HLA-A2.
-
Tetrahydrodehydrodic...
Tetrahydrodehydrodiconiferyl alcohol is a natural product.